Clinical Trial Update: A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating SHR0302 in non-segmental vitiligo, using both tablet and topical gel formulations, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• SHR0302 base gel (SHR0302)
• SHR0302 tablets (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Non-segmental Vitiligo | Phase 2 | Status: RECRUITING